The role of GLP-1 in the life and death of pancreatic beta cells
- PMID: 15655712
- DOI: 10.1055/s-2004-826167
The role of GLP-1 in the life and death of pancreatic beta cells
Abstract
Glucagon-like peptide-1 (GLP-1), a peptide hormone produce by intestinal cells, has recently been shown to be capable of modulating islet cell mass. Administration of GLP-1 to rodent models of type 2 diabetes ameliorates insulin secretion, induces the replication of islet cells, and promotes islet-cell neogenesis from pancreatic ductal cells susceptible to transdifferentiate in insulin-producing cells. In addition, an anti-apoptotic effect of GLP-1 has been described in hyperglycemic animal models, using freshly isolated human islets or cultured beta cell lines exposed to various pro-apoptotic stimuli. The aim of this article is to review those reports that have emphasized the role of GLP-1 as a regulator of islet cell mass.
Similar articles
-
Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E875-81. doi: 10.1152/ajpendo.00007.2004. Am J Physiol Endocrinol Metab. 2004. PMID: 15140754 Review.
-
GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):115-23. doi: 10.1002/dmrr.357. Diabetes Metab Res Rev. 2003. PMID: 12673779 Review.
-
Glucagon-like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic beta-cells.Biochem Biophys Res Commun. 2000 Aug 11;274(3):616-9. doi: 10.1006/bbrc.2000.3198. Biochem Biophys Res Commun. 2000. PMID: 10924326
-
Glucagon-like peptide-1.Recent Prog Horm Res. 2001;56:377-99. doi: 10.1210/rp.56.1.377. Recent Prog Horm Res. 2001. PMID: 11237222 Review.
-
GLP-1 and extra-islet effects.Horm Metab Res. 2004 Nov-Dec;36(11-12):842-5. doi: 10.1055/s-2004-826173. Horm Metab Res. 2004. PMID: 15655717 Review.
Cited by
-
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.Curr Diab Rep. 2007 Oct;7(5):340-7. doi: 10.1007/s11892-007-0056-9. Curr Diab Rep. 2007. PMID: 18173966 Review.
-
Beta-cell failure in type 2 diabetes mellitus.Curr Diab Rep. 2008 Jun;8(3):179-84. doi: 10.1007/s11892-008-0031-0. Curr Diab Rep. 2008. PMID: 18625113 Review.
-
New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins.Rev Diabet Stud. 2005 Summer;2(2):61-9. doi: 10.1900/RDS.2005.2.61. Epub 2005 Aug 10. Rev Diabet Stud. 2005. PMID: 17491680 Free PMC article.
-
Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy.Drug Des Devel Ther. 2016 Jul 19;10:2263-70. doi: 10.2147/DDDT.S93076. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27486305 Free PMC article. Review.
-
Regulation of dietary fiber on intestinal microorganisms and its effects on animal health.Anim Nutr. 2023 Jun 22;14:356-369. doi: 10.1016/j.aninu.2023.06.004. eCollection 2023 Sep. Anim Nutr. 2023. PMID: 37635930 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources